Supplementary Online Content Chow CK, Koon KT, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities from high-, middle-, and low-income countries. JAMA. doi:10.1001/jama.2013.184182. eTable 1. Prevalence of Different Stages of Hypertension (Defined by Blood Pressure Measurements at Time of Survey Only) by Country Income, Gender, and Region eTable 2. Adjusted Mean BP and Prevalence of Hypertension (Adjusted for Age, Sex, Urban/Rural Location) eTable 3. Prevalence of Hypertension by Age Group, Income Status, Sex, and Geographic Region (Unadjusted) eTable 4. Prevalence of Different Stages of Hypertension Stratified by Education (Age, Gender, Location, and Education Adjusted as Relevant) eTable 5. Use of 2 or More BP-Lowering Medications as a Percentage of Those With Hypertension and as a Percentage of Those on Treatments for Hypertension by Economic Status of Country eTable 6. Use of 2 or More BP-Lowering Medications by Education (Age, Gender, Location, and Economic Status Adjusted as Relevant Among All Hypertensive Participants) eTable 7. Prevalence of Hypertension, Awareness, Treatment, and Control in PURE—Absolute Numbers and Percentages eTable 8. PURE Study—Location of Communities and Methodology of Household Sampling eTable 9. Prevalence of Hypertension Stratified by Education (Age, Gender, Location, and Country Economic Status Adjusted as Relevant) (Figure 1A) eTable 10. Awareness of Hypertension Stratified by Education (Age, Gender, Location, and Country Economic Status Adjusted As Relevant) (Figure 1B) eTable 11. Treated Hypertension Stratified by Education (Age, Gender, Location, and Country Economic Status Adjusted as Relevant) (Figure 1C) eTable 12. Controlled Hypertension Stratified by Education (Age, Gender, Location, and Country Economic Status Adjusted as Relevant) (Figure 1D) This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 eTable 1. Prevalence of Different Stages of Hypertension (Defined by Blood Pressure Measurements at Time of Survey Only) by Country Income, Gender, and Region Stage 1 HT Stage 2 HT Stage 3 HT Pre hypertension (120- SBP >= 140 or DBP >= SBP >= 160 or DBP SBP >= 180 or DBP Optimal BP (<120/80) 139/80-89) 90 >= 100 >= 110 Number No. [%] No. [%] No. [%] No. [%] No. [%] HIC 15418 3919(25.4) 6408(41.6) 3566(23.1) 1171( 7.6) 354( 2.3) UMIC 36463 8262(22.7) 12901(35.4) 9251(25.4) 3909(10.7) 2140( 5.9) LMIC 58476 15829(27.1) 21660(37.0) 12766(21.8) 5562( 9.5) 2659( 4.5) LIC 31685 11444(36.1) 11331(35.8) 5613(17.7) 2129( 6.7) 1168( 3.7) Female 82607 25833(31.3) 28975(35.1) 17093(20.7) 7143( 8.6) 3563( 4.3) Male 59435 13621(22.9) 23325(39.2) 14103(23.7) 5628( 9.5) 2758( 4.6) South Asia 30903 11289(36.5) 11105(35.9) 5441(17.6) 2026( 6.6) 1042( 3.4) China 45108 11165(24.8) 16542(36.7) 10428(23.1) 4702(10.4) 2271( 5.0) Malaysia 11324 2490(22.0) 4190(37.0) 2840(25.1) 1194(10.5) 610( 5.4) Africa 3813 680(17.8) 1109(29.1) 980(25.7) 571(15.0) 473(12.4) N.America/ EU 20449 5208(25.5) 8137(39.8) 4778(23.4) 1688( 8.3) 638( 3.1) Middle East 6931 2508(36.2) 2703(39.0) 1193(17.2) 396( 5.7) 131( 1.9) S. America 23514 6114(26.0) 8514(36.2) 5536(23.5) 2194( 9.3) 1156( 4.9) All Countries 142042 39454(27.8) 52300(36.8) 31196(22.0) 12771( 9.0) 6321( 4.5) Cut off points for description of the population distribution based on the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7).14 Stage 1,2 and 3 HT groups are not mutually exclusive, stage 1 HT includes stage 2 & 3, Stage 2 HT includes stage 3. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 eTable 2. Adjusted Mean BP and Prevalence of Hypertension (Adjusted for Age, Sex, Urban/Rural Location) % (95% CI) mm Hg (95% CI) Self-Reported Hypertension on Treatment Country SBP DBP or BP ≥140/90 or BP ≥160/100 Stage 1 HT Stage 2 HT Stage 3 HT Overall 132.7(130.8-134.5) 83.5( 82.5- 84.4) 44.2(40.8-47.7) 24.5(22.3-26.8) 22.3(20.6-24.1) 8.5( 7.7- 9.5) 4.2( 3.5- 4.9) Canada 127.1(121.9-132.4) 79.4( 76.6- 82.1) 30.7(22.7-40.1) 16.0(11.7-21.5) 18.9(14.7-24.0) 4.2( 3.0- 5.8) 1.0( 0.6- 1.7) Sweden 131.7(122.6-140.7) 86.5( 81.8- 91.3) 42.3(26.4-59.9) 19.8(11.7-31.5) 24.2(16.0-34.9) 10.1( 5.9-16.8) 3.6( 1.5- 8.6) UAE 136.9(127.8-146.0) 84.4( 79.6- 89.2) 55.6(37.9-72.0) 33.6(21.2-48.9) 29.9(20.1-42.1) 12.0( 6.9-19.9) 3.9( 1.5- 9.6) Argentina 135.0(126.0-144.1) 82.8( 78.1- 87.5) 50.3(33.2-67.3) 29.6(18.5-44.0) 26.6(17.8-37.8) 9.6( 5.6-15.9) 4.3( 1.8-10.1) Brazil 131.5(122.4-140.5) 86.5( 81.8- 91.3) 50.1(33.0-67.1) 33.3(21.2-48.2) 23.3(15.3-33.7) 8.5( 4.9-14.3) 4.7( 2.0-11.1) Chile 130.7(121.6-139.8) 82.3( 77.6- 87.1) 44.3(28.1-61.9) 26.5(16.2-40.2) 22.3(14.6-32.6) 7.2( 4.1-12.2) 4.2( 1.7-10.0) Malaysia 134.9(129.7-140.1) 81.1( 78.4- 83.8) 44.2(34.4-54.4) 24.3(18.3-31.5) 23.6(18.6-29.5) 8.9( 6.5-12.1) 4.6( 2.7- 7.6) Poland 143.3(134.2-152.4) 85.8( 81.1- 90.6) 63.8(46.3-78.3) 37.8(24.5-53.2) 32.0(21.8-44.2) 14.0( 8.3-22.6) 6.6( 2.8-15.2) South Africa 140.1(133.7-146.5) 90.1( 86.7- 93.5) 63.0(50.6-73.8) 36.2(26.7-47.0) 28.0(21.1-36.0) 15.7(10.9-22.0) 11.2( 6.2-19.5) Turkey 129.2(126.0-132.5) 80.0( 78.2- 81.8) 38.8(32.8-45.3) 23.5(19.5-28.0) 19.2(16.2-22.6) 6.3( 5.0- 8.0) 3.2( 2.2- 4.6) China 132.5(129.9-135.2) 82.6( 81.3- 84.0) 38.5(33.7-43.5) 19.1(16.5-22.0) 21.4(18.9-24.0) 8.8( 7.5-10.2) 3.9( 3.0- 5.1) Colombia 128.1(123.6-132.7) 80.7( 78.4- 83.1) 34.4(26.8-42.9) 19.3(14.8-24.7) 18.0(14.4-22.3) 6.6( 5.0- 8.8) 3.4( 2.1- 5.3) Iran 126.2(117.1-135.2) 78.0( 73.3- 82.7) 27.7(15.8-43.8) 15.2( 8.8-25.1) 16.0(10.2-24.2) 4.7( 2.7- 8.2) 1.5( 0.6- 3.7) Bangladesh 130.5(121.5-139.6) 85.4( 80.6- 90.1) 46.7(30.0-64.1) 25.6(15.6-39.2) 21.2(13.7-31.1) 12.7( 7.5-20.7) 8.3( 3.5-18.6) India 128.9(124.9-133.0) 80.8( 78.7- 83.0) 33.3(26.7-40.7) 15.5(12.2-19.5) 18.6(15.4-22.4) 6.0( 4.7- 7.6) 2.7( 1.8- 4.0) Pakistan 126.9(117.8-136.0) 83.4( 78.6- 88.1) 37.6(22.7-55.2) 20.3(11.9-32.5) 19.1(12.2-28.7) 6.9( 3.9-12.1) 3.8( 1.5- 9.2) Zimbabwe 141.8(132.7-151.0) 88.8( 83.9- 93.6) 54.4(36.7-71.1) 32.3(20.1-47.4) 21.3(13.6-31.7) 11.3( 6.5-19.0) 13.1( 5.6-27.6) HIC 130.0(125.2-134.8) 81.8( 78.8- 84.8) 37.6(29.1-46.9) 19.6(15.0-25.2) 21.8(17.9-26.3) 6.2( 4.4- 8.8) 1.7( 1.0- 2.9) UMIC 133.0(130.4-135.6) 82.5( 80.8- 84.1) 45.9(40.8-51.2) 27.0(23.6-30.7) 22.8(20.4-25.3) 8.5( 7.0-10.3) 4.5( 3.3- 6.0) LMIC 131.1(128.5-133.7) 81.9( 80.3- 83.6) 36.8(32.1-41.8) 18.9(16.3-21.7) 20.2(18.1-22.4) 7.9( 6.6- 9.5) 3.6( 2.7- 4.8) LIC- 130.5(126.7-134.3) 82.7( 80.3- 85.1) 37.9(31.1-45.2) 18.8(15.2-23.1) 19.3(16.4-22.5) 7.2( 5.5- 9.5) 4.0( 2.6- 6.0) © 2013 American Medical Association.